-
Electronic IRB submission technology can be of great use to even small research institutions, once it's integrated with existing technology.
-
IRBs often seek new members who are experienced scientists, professors, and medical doctors. But they might be missing an opportunity to educate and engage young scientists by overlooking that pool of potential ethics board members.
-
[Editor's note: This is the second part of a two-part series on how IRBs can cut costs during these lean budget times. States are forcing higher education payroll and departmental budget cuts across the nation, and IRBs likely will be impacted. IRB Advisor asked a number of IRB efficiency experts to discuss how IRBs can make do with fewer resources. In this month's issue we present a case study of how one university approached IRB cost-cutting. In the April, 2009, issue, there were stories on collecting outcome data and making your IRB more cost-efficient.]
-
Large research institutions can improve IRB consistency, education, and networking by establishing an oversight board that will bring IRB chairs together at committee meetings.
-
Patricia MacCubbin, MS, executive director of research conduct and special advisor to the vice chancellor for research at the City University of New York (CUNY) in New York City offers some suggestions for educating researchers and IRB members in a large, diverse organization.
-
IRBs have to adhere to regulations on diversifying their board memberships, but specifically finding the appropriate expertise for any particular meeting and finding dedicated non-scientist members are major challenges IRBs face.
-
An Institute of Medicine committee has proposed a bold solution to the vexing problem of trying to conduct healthcare research under the Health Insurance Portability and Accountability Act's Privacy Rule.
-
Doubtless, few IRBs are holding their collective breaths waiting for a massive overhaul of privacy provisions in health research. And even the IOM Committee on Health Research and the Privacy of Health Information's less ambitious recommendations for HHS guidance on use of HIPAA may take a little while.
-
Is reluctance to permit exceptions from informed consent in emergency research (EICER) preventing important studies from moving forward?
-
When looking at a study that would involve the use of the exception from informed consent for emergency research (EICER), IRBs first should consider whether the exception is necessary and appropriate, says Graham Nichol, MD, MPH, medical director of the University of Washington Clinical Trials Center in Seattle.
